# Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography

> **NCT01683825** · PHASE4 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 23 (actual)

## Conditions studied

- Cardiac Amyloidosis

## Interventions

- **DRUG:** F-18 florbetapir PET

## Key facts

- **NCT ID:** NCT01683825
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-23
- **Primary completion:** 2018-10-04
- **Final completion:** 2018-10-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01683825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01683825, "Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01683825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*